7 results
Checklist for Evaluation of New-Onset Delirium in the ICU

Initial assessment 
 - 
Vital signs, neuro exam
Delirium in the ICU ... Review recent events ... - Relevant drug ... Evaluation #Workup #MICU ... #CriticalCare #Diagnosis
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
Delirium (PAD) in the ICU ... Addressing the ICU ... A dissociative drug ... non-OTC prolonging agent ... #CriticalCare #diagnosis
Delirium in the ICU

Defining delirium
Types of delirium
Consequences of delirium
Reversible causes of delirium
Drug-induced delirium
Non-pharmacologic management of delirium
Pharmacologic
Delirium in the ICU ... causes of delirium Drug-induced ... theABofPharmaC #ICU ... #Delirium #pharmacology ... #criticalcare #diagnosis
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Lymphohistiocytosis (HLH) Pathophysiology ... Auto-amplification loop Diagnosis ... immune deficiency, Drugs ... of emergency, ICU ... Lymphohistiocytosis #diagnosis
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Other triggering events ... bulbar muscles DIAGNOSIS ... the underlying pathophysiology ... intensive care unit (ICU ... Barre #Syndrome #diagnosis
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
Antifungal agents ... Weaknesses: High MIC ... Weaknesses: Therapeutic drug ... Coccidioidomycosis #pharmacology ... management #treatment #coccidioides
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
of antifungal agents ... tolerable • High MIC ... • Therapeutic drug ... Coccidioidomycosis #coccidioides ... comparison #table #pharmacology